Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
about
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistancePlasticity of the Leishmania genome leading to gene copy number variations and drug resistanceGene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensisMolecular mechanisms of drug resistance in natural Leishmania populations vary with genetic backgroundRole of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovaniProteomic and genomic analyses of antimony resistant Leishmania infantum mutantIn vitro susceptibilities of wild and drug resistant leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacyIntrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensisSpecies-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovaniDrug resistance in eukaryotic microorganisms.Novel arylimidamides for treatment of visceral leishmaniasis.Characterization of Leishmania donovani aquaporins shows presence of subcellular aquaporins similar to tonoplast intrinsic proteins of plantsHeterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.Antimony resistance in leishmania, focusing on experimental research.Arsenic and antimony transporters in eukaryotesModulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.Functional role of lysine 12 in Leishmania major AQP1Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.Aquaglyceroporins: generalized metalloid channels.Leishmania antimony resistance: what we know what we can learn from the field.Evaluating drug resistance in visceral leishmaniasis: the challenges.A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates.Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis.Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern
P2860
Q24633552-F03E05A7-1935-4849-A56B-8649DC32A829Q28074697-1872E389-765A-4C0B-B3E4-E0FA946EC5CCQ28478242-82510D46-05BB-404E-82C9-76CE99B5B3ADQ28481297-8911693C-6ABE-4B36-902A-09CBC8558888Q28533525-E99BC76F-226C-4EC3-8E8E-11D6C1C67B2EQ28535444-13DA0899-BD04-449A-B466-85625704C868Q28536688-FDDA34D3-0A40-4F71-ABB9-0B05DA73FB74Q28543469-F6548004-449F-4EC8-AFF3-905B74E0C3E9Q28543678-22D0F4E3-ADFB-4E0A-9E99-6C6A24803A5AQ28547415-9D24D088-8A03-45BA-9030-5EFE4228DC23Q30248243-D2788590-E32B-4A19-AE9C-DCF66723F488Q33876693-6CEE207D-EAF0-40AE-A416-E10AAD590893Q34039441-214E90AA-DB34-4022-8A79-6F73FE40AF0BQ34058276-53B33955-F482-4878-8AC1-4E2086B9D988Q35607561-39DDECD6-99BE-4D07-9C76-4BDD6A2C814BQ35866055-3383C8FA-26A0-4F30-B7E2-501AA633A9CAQ36223332-6F5926AD-4447-44BB-AF43-134BD08FFC87Q36446143-E01AE2AC-4741-4019-8E87-A637FDCE155EQ36957213-DEBFD345-F065-4337-933E-DC2531354B80Q37649779-24C9CB42-FF60-4A2C-BCF0-7657EB26D2D1Q37907925-84BCF095-E5BF-44C9-B363-76E24B8B0EABQ39014583-38A3FA0A-6F2B-4DC8-B974-6E288A977DB8Q39515983-447F11F3-8F35-4139-AD68-236F6A0495ACQ40078925-9EB6677E-359A-4928-864E-54736AD7165DQ41678461-26C1347D-DB49-441C-89C8-271DD2D3AEC2Q42321448-8BFBDE0C-8DDB-4C80-BA95-AC1F6E2369F7Q42407627-BD5216B5-F988-4882-A359-510E1BB8D0F5Q42481653-4613B37B-29FB-4FD2-B0B8-F436D82A23B9Q42548785-D37053E4-0A27-4BCE-A861-A6FB6D02455DQ46380663-05B5BCFF-A6D0-4D9A-8374-137D57E4DB9FQ58805904-074D73A6-3FCF-439A-959A-09651F72A04A
P2860
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@en
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@nl
type
label
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@en
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@nl
prefLabel
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@en
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@nl
P2093
P2860
P356
P1476
Assessing aquaglyceroporin gen ...... eishmania donovani from India.
@en
P2093
Mahendra Maharjan
Mitali Chatterjee
Swati Mandal
P2860
P304
P356
10.1093/JAC/DKP468
P407
P577
2010-01-12T00:00:00Z